Contract Service Directory

Dalton Pharma Services





Company Headquarters

349 Wildcat Rd.
Toronto, ON M3J 2S3
Canada

Company Description

Dalton Pharma Services is a leading North American, Health Canada approved, FDA registered, cGMP organization providing integrated drug discovery, development and manufacturing services. We deliver fully integrated solutions (drug discovery, formulation & process development, custom synthesis, cGMP sterile fill/finish of liquids & powders, cGMP API manufacturing and/or dosage form manufacturing and Accelerated Stability Testing) with an emphasis on speed, flexibility & quality.

Contract Service Directory

    Content From Dalton Pharma Services

    Related Content

    • Breaking News | Industry News | Laboratory Testing
      Dalton Pharma Services Expands Capabilities

      Dalton Pharma Services Expands Capabilities

      Offers extractables and leachables testing services.
      Contract Pharma Staff 11.10.20

    • THE CENTRE FOR CELL AND VECTOR PRODUCTION (CCVP)

      A Transparent and Flexible Approach to Manufacturing

    • Breaking News | CRO News | Promotions & Moves
      Parexel Adds Experts to Regulatory Consulting Group

      Parexel Adds Experts to Regulatory Consulting Group

      Four new hires from U.S. FDA and MHRA will serve as technical vice presidents
      12.10.19


    • Breaking News | Drug Development | Trials & Filings
      SK Bio Gains FDA Approval for XCOPRI

      SK Bio Gains FDA Approval for XCOPRI

      Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval
      11.25.19

    • When Life Gives You Lemons…Raise Your Drug Prices

      When Life Gives You Lemons…Raise Your Drug Prices

      The hidden effect of economic models on global drug supply and shortages.
      Ben Locwin 11.20.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19


    • cGMP Manufacture | Drug Development
      Contract Pharma’s 20th Anniversary Series: CDMO Insight

      Contract Pharma’s 20th Anniversary Series: CDMO Insight

      JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.
      Kristin Brooks, Contract Pharma 11.01.19


    • How Can a Contract Development and Manufacturing Organization Advance a Cell & Gene Therapy Product?



    • Regulatory Affairs
      Quality Metrics Feedback

      Quality Metrics Feedback

      A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholders
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19


    • Drug Development | Trials & Filings
      Roche Wins Two Approvals for Cancer Drug Rozlytrek

      Roche Wins Two Approvals for Cancer Drug Rozlytrek

      Becomes third tumor-agnostic drug to win FDA Approval
      08.16.19